Completed
Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma
NCT00061672
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +8 more
- Locations
-
- Hematology Oncology Associates Phoenix, Arizona, United States
- Arizona Clinical Research Center Tucson, Arizona, United States
- USC - Norris Cancer Center Los Angeles, California, United States
- The Center for Hematology-Oncology Boca Raton, Florida, United States